Cluster 1 mainly presented alterations in MAPT and a higher percentage of people with APOE e4 allele (therefore, with a higher risk of developing dementia due to AD), as well as higher tau levels at the dementia stage. This evidence concerns the gene MAPT and Alzheimer disease.